Clinical Trials Browser

Phase 1/2 × INDUSTRY × SCLC × Clear all

NCT04750239 2023-08-14

Safety and Clinical Activity of Nivatrotamab in Relapsed/Recurrent Metastatic Small-cell Lung Cancer

Phase 1/2 Terminated

3 enrolled 9 charts

SCLC